Exhibit 10.2
VIKING STOCK OPTION AGREEMENT
-----------------------------
STOCK OPTION AGREEMENT, dated as of May 18, 1998 (the "Agreement"),
between Office Depot, Inc., a Delaware corporation (the "Grantee"), and
Viking Office Products, Inc., a California corporation (the "Grantor").
WHEREAS, the Grantee, the Grantor and VK Acquisition Corp., a
California corporation and a wholly-owned subsidiary of the Grantee
("Newco"), are entering into an Agreement and Plan of Merger, dated as of the
date hereof (the "Merger Agreement"), which provides, among other things, for
the merger (the "Merger") of Newco with and into the Grantee;
WHEREAS, as a condition to its willingness to enter into the Merger
Agreement, the Grantee has requested that the Grantor grant to the Grantee an
option to purchase the shares of Common Stock of the Grantor (the "Common
Stock") covered hereby, upon the terms and subject to the conditions hereof;
and
WHEREAS, in order to induce the Grantee to enter into the Merger
Agreement, the Grantor is willing to grant the Grantee the requested option.
NOW, THEREFORE, in consideration of the premises and the mutual
covenants and agreements set forth herein, the parties hereto agree as
follows:
1. The Option; Exercise; Adjustments; Payment of Spread;
Termination.
(a) Contemporaneously herewith the Grantee, Newco and the Grantor
are entering into the Merger Agreement, and Grantor has amended the Viking
Rights Plan (as defined in the Merger Agreement). Subject to the other terms
and conditions set forth herein, the Grantor hereby grants to the Grantee an
irrevocable option (the "Option") to purchase up to 16,929,500 shares
(representing approximately 19.9% of the outstanding shares of Common Stock
as of the date hereof) of Common Stock (the "Shares") at a cash purchase
price equal to $33.60 per Share (the "Purchase Price"). The Option may be
exercised by the Grantee, in whole or in part, at any time, or from time to
time, following the occurrence of one of the events set forth in Section 2(c)
hereof and prior to the termination of the Option in accordance with the
terms of this Agreement.
(b) In the event of any change in the number of issued and
outstanding shares of Common Stock by reason of any stock dividend, stock
split, split-up, recapitalization, merger or other change in the corporate or
capital structure of the Grantor, the number of Shares subject to the Option
and the purchase price per Share shall be appropriately adjusted to restore
the Grantee to its rights hereunder, including its right to purchase Shares
representing 19.9% of the capital stock of the Grantor entitled to vote
generally for the election of the directors of the Grantor which is issued
and outstanding immediately prior to the exercise of the Option at an
aggregate purchase price equal to the Purchase Price multiplied by
16,929,500.
(c) In the event the Grantee wishes to exercise the Option, the
Grantee shall send a written notice to the Grantor (the "Exercise Notice")
specifying a date (subject to the requirements of the Xxxx-Xxxxx-Xxxxxx
Antitrust Improvements Act of 1976, as amended (the "HSR Act")) not later
than 10 business days and not earlier than the next business day following
the date such notice is given for the closing of such purchase.
(d) If an Alternative Transaction involving Grantor is consummated
within twelve months after termination of the Merger Agreement such that the
$50,000,000 fee is payable pursuant to Section 8.03(c) of the Merger
Agreement, then the Grantee may (i) at any time the Option is then
exercisable pursuant to the terms of Section 1(a) hereof elect, in lieu of
exercising the Option to purchase Shares provided in Section 1(a) hereof, to
send a written notice to the Grantor (the "Cash Exercise Notice") specifying
a date not later than 20 business days and not earlier than 10 business days
following the date such notice is given on which date the Grantor shall pay
to the Grantee an amount in cash equal to the Spread (as hereinafter defined)
multiplied by all or such portion of the Shares subject to the Option as
Grantee shall specify, or (ii) at any time prior to 30 days after the first
anniversary of the Merger Termination Date (as defined in Section 1(e)), if
the Grantee has exercised the Option and purchased the Shares hereunder,
Grantee may send a written notice to the Grantor (the "Put Notice")
specifying a date not later than 20 business days and not earlier than 10
business days following the date such notice is given on which date the
Grantee may sell to the Grantor Shares purchased hereunder and the Grantor
shall pay to the Grantee an amount in cash equal to the higher of (m) the
Alternative Purchase Price (as hereinafter defined) or (n) the average of the
closing sales prices of the shares of Common Stock on Nasdaq for the five
trading days ending five days prior to the date of the Put Notice, multiplied
by the number of such Shares sold by the Grantee to the Grantor on such date
(such purchase and sale to be closed in a manner substantially consistent
with the procedures outlined in Section 3 hereof). As used herein "Spread"
shall mean the excess, if any, over the Purchase Price of the higher of (x)
if applicable, the highest price per share of Common Stock (including any
brokerage commissions, transfer taxes and soliciting dealers' fees) paid by
any person in an Alternative Transaction (as defined in Section 8.03(g) of
the Merger Agreement) (the "Alternative Purchase Price") or (y) the average
of the closing sales prices of the shares of Common Stock on the Nasdaq for
the five trading days ending five days prior to the date of the Cash Exercise
Notice. If the Alternative Purchase Price includes any property other than
cash, the Alternative Purchase Price shall be the sum of (A) the fixed cash
amount, if any, included in the Alternative Purchase Price plus (B) the fair
market value of such other property determined in accordance with the
procedures set forth in Section 7(b) (but using the date of the Cash Exercise
Notice or the Put Notice, as the case may be). Upon exercise of the
Grantee's right to receive cash pursuant to Section 1(d)(i) and the payment
of such cash to the Grantee, the obligations of the Grantor to deliver Shares
pursuant to Section 3 shall be terminated with respect to such number of
Shares for which the Grantee shall have elected to be paid the Spread.
(e) The right to exercise the Option shall terminate at the
earliest of (i) the Effective Time (as defined in the Merger Agreement), (ii)
the termination of the Merger Agreement pursuant to circumstances under which
the Grantee is not entitled to receive the termination fee pursuant to
Section 8.03(c) of the Merger Agreement, (iii) the date on which the Grantee
realizes a Total Profit equal to the Profit Limit (as such terms are defined
in Section 10) and (iv) 180 days after the date (the "Merger Termination
Date") on which the Merger Agreement is terminated (the date referred to in
clause (iv) being hereinafter referred to as the "Option Expiration Date");
provided that if the Option cannot be exercised or the Shares cannot be
delivered to Grantee upon such exercise because the conditions set forth in
Section 2(a) or Section 2(b) hereof have not yet been satisfied, the Option
Expiration Date shall be extended until 30 days after such impediment to
exercise has been removed.
2. Conditions to Delivery of Shares. The Grantor's obligation to
deliver Shares upon exercise of the Option is subject only to the conditions
that:
(a) No preliminary or permanent injunction or other order issued
by any federal or state court of competent jurisdiction in the United States
prohibiting the delivery of the Shares shall be in effect; and
(b) Any applicable waiting periods under the HSR Act shall have
expired or been terminated; and
(c) The Grantee shall have become entitled to terminate the Merger
Agreement under circumstances that would entitle the Grantee to receive some
or all of the termination fee pursuant to Section 8.03(c) of the Merger
Agreement.
3. The Closing.
(a) Any closing hereunder shall take place on the date specified
by the Grantee in its Exercise Notice at 9:00 A.M., local time, at the
offices of Xxxxxx & Xxxxxxx, 000 Xxxx Xxxxx Xxxxxx, Xxxxx 0000, Xxx Xxxxxxx,
Xxxxxxxxxx, or, if the conditions set forth in Section 2(a) or 2(b) have not
then been satisfied, on the second business day following the satisfaction of
such conditions, or at such other time and place as the parties hereto may
agree (the "Closing Date"). On the Closing Date, the Grantor will deliver to
the Grantee a certificate or certificates, duly endorsed (or accompanied by
duly executed stock powers), representing the Shares in the denominations
designated by the Grantee in its Exercise Notice and the Grantee will
purchase such Shares from the Grantor at the price per Share equal to the
Purchase Price. Any payment made by the Grantee to the Grantor, or by the
Grantor to the Grantee, pursuant to this Agreement shall be made by certified
or official bank check or by wire transfer of federal funds to a bank
designated by the party receiving such funds.
(b) The certificates representing the Shares may bear an
appropriate legend relating to the fact that such Shares have not been
registered under the Securities Act of 1933, as amended (the "Securities
Act").
4. Representations and Warranties of the Grantor. The Grantor
represents and warrants to the Grantee that: (a) the Grantor is a
corporation duly organized, validly existing and in good standing under the
laws of the State of California and has the requisite corporate power and
authority to enter into and perform this Agreement; (b) the execution and
delivery of this Agreement by the Grantor and the consummation by it of the
transactions contemplated hereby have been duly authorized by the Board of
Directors of the Grantor and this Agreement has been duly executed and
delivered by a duly authorized officer of the Grantor and constitutes a valid
and binding obligation of the Grantor, enforceable in accordance with its
terms, subject to bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability relating
to or affecting creditors' rights, to general equity principles and to the
California General Corporation Law; (c) the Grantor has taken all necessary
corporate action to authorize and reserve the Shares issuable upon exercise
of the Option and the Shares, when issued and delivered by the Grantor upon
exercise of the Option, will be duly authorized, validly issued, fully paid
and non-assessable and free of any lien, security interest or other adverse
claim and free of any preemptive rights; (d) except as otherwise required by
the HSR Act, the execution and delivery of this Agreement by the Grantor and
the consummation by it of the transactions contemplated hereby do not require
the consent, waiver, approval or authorization of or any filing with any
person or public authority and will not violate, require a consent or waiver
under, result in a breach of or the acceleration of any obligation under, or
constitute a default under, any provision of any charter or by-law,
indenture, mortgage, lien, lease, agreement, contract, instrument, order,
law, rule, regulation, stock market rule, judgment, ordinance, decree or
restriction by which the Grantor or any of its subsidiaries or any of their
respective properties or assets is bound; (e) no "fair price", "moratorium",
"control share acquisition" or other form of antitakeover statute or
regulation is or shall be applicable to the acquisition of Shares pursuant to
this Agreement; and (f) the Grantor has taken all corporate action necessary
so that the grant and any subsequent exercise of the Option by the Grantee
will not result in the separation or exercisability of rights under the
Rights Agreement, dated as of January 20, 1997 between the Grantor and the
American Stock Transfer and Trust Company, as Rights Agent.
5. Representations and Warranties of the Grantee. The Grantee
represents and warrants to the Grantor that: (a) the execution and delivery
of this Agreement by the Grantee and the consummation by it of the
transactions contemplated hereby have been duly authorized by all necessary
corporate action on the part of the Grantee and this Agreement has been duly
executed and delivered by a duly authorized officer of the Grantee and
constitutes a valid and binding obligation of the Grantee; and (b) the
Grantee is acquiring the Option and, if and when it exercises the Option,
will be acquiring the Shares issuable upon the exercise thereof for its own
account and not with a view to distribution or resale in any manner which
would be in violation of the Securities Act.
6. Listing of Shares; HSR Act Filings; Governmental Consents.
Subject to applicable law and the rules and regulations of the Nasdaq
National Market, the Grantor shall (i) promptly file a notice to list the
Shares on the Nasdaq National Market and (ii) make, as promptly as
practicable, all necessary filings by the Grantor under the HSR Act and use
its best efforts to obtain all necessary approvals thereunder as promptly as
practicable; provided, however, that if the Grantor is unable to effect such
listing on the Nasdaq National Market by the Closing Date, the Grantor will
nevertheless be obligated to deliver the Shares upon the Closing Date. Each
of the parties hereto will use its best efforts to obtain consents of all
third parties and governmental authorities, if any, necessary to the
consummation of the transactions contemplated.
7. Right of First Refusal. If the Grantee, at any time prior to
the earlier of (a) the occurrence of a Change in Control Event (as defined
herein) or (b) 30 days after the first anniversary of the Merger Termination
Date, seeks to sell all or any part of the Shares (i) in a transaction
registered under the Securities Act (other than in a registered public
offering in which the underwriters are instructed to achieve a broad public
distribution) or (ii) in a transaction not required to be registered under
the Securities Act (other than in a transfer by operation of law upon
consummation of a merger), it shall give the Grantor (or a designee of the
Grantor) the opportunity, in the following manner, to purchase such Shares:
(a) The Grantee shall give notice to the Grantor in writing of its
intent to sell Shares (a "Disposition Notice"), specifying the number of
Shares to be sold, the price and, if applicable, the material terms of any
agreement relating thereto. For purposes of this Section 7, if the
Disposition Notice is given with respect to the sale of the Shares pursuant
to a tender or exchange officer, it shall be assumed that all Shares tendered
will be accepted for payment. The Disposition Notice may be given at any
time, including prior to the giving of any Exercise Notice.
(b) The Grantor or its designee shall have the right, exercisable
by written notice given to the Grantee within five business days after
receipt of a Disposition Notice (or, if applicable, in the case of a proposed
sale pursuant to a tender or exchange offer for shares of Common Stock, by
written notice given to the Grantee at least two business days prior to the
then announced expiration date of such tender or exchange offer (the
"Expiration Date") if such Disposition Notice was given at least four
business days prior to such Expiration Date), to purchase all, but not less
than all, of the Shares specified in the Disposition Notice at the price set
forth in the Disposition Notice. If the purchase price specified in the
Disposition Notice includes any property other than cash, the purchase price
to be paid by the Grantor shall be an amount of cash equal to the sum of
(i) the cash included in the purchase price plus (ii) the fair market value
of such other property at the date of the Disposition Notice. If such other
property consists of securities with an existing public trading market, the
average closing price (or the average closing bid and asked price if closing
prices are unavailable) for such securities on their principal public trading
market for the five trading days ending five days prior to the date of the
Disposition Notice shall be deemed to equal the fair market value of such
property. If such other property consists of something other than cash or
securities with an existing public trading market and, at the time of the
closing referred to in paragraph (c) below, agreement on the value of such
other property has not been reached, the higher of (i) the cash included in
the purchase price and (ii) the average closing price of the Common Stock on
the Nasdaq National Market for the five trading days ending five days prior
to the date of the Disposition Notice shall be used as the per share purchase
price; provided, however, that promptly after the closing, the Grantee and
the Grantor or its designee, as the case may be, shall settle any additional
amounts to be paid or returned as a result of the determination of fair
market value of such other property made by a nationally recognized
investment banking firm selected by the Grantor and approved by the Grantee
within 30 days of the closing. Such determination shall be final and binding
on all parties hereto. If, at the time of the purchase of any Shares by the
Grantor (or its designee) pursuant to this Section 7, a tender or exchange
offer is outstanding, then the Grantor (or its designee) shall agree at the
time of such purchase to promptly pay to Grantee from time to time such
additional amounts, if any, so that the consideration received by Grantee
with respect to each Share shall be equal to the highest price paid for a
share of Common Stock pursuant to such tender or exchange, or pursuant to any
other tender or exchange offer outstanding at any time such tender or
exchange offer is outstanding.
(c) If the Grantor exercises its right of first refusal hereunder,
the closing of the purchase of the Shares with respect to which such right
has been exercised shall take place within five business days after the
notice of such exercise (or, if applicable, in the case of a tender or
exchange offer, no later than one business day prior to the expiration date
of the offer if written notice was given within the time set forth in the
parenthetical in the first sentence of paragraph (b) above); provided,
however, that at any time prior to the closing of the purchase of Shares
hereunder, the Grantee may determine not to sell the Shares and revoke the
Disposition Notice and, by so doing, cancel the Grantor's right of first
refusal with respect to the disposition in question. The Grantor (or its
designee) shall pay for the Shares in immediately available funds.
(d) If the Grantor does not exercise its right of first refusal
hereunder within the time specified for such exercise, the Grantee shall be
free for 90 days following the expiration of such time for exercise to sell
the Shares (or enter into an agreement to sell the Shares) specified in the
Disposition Notice, at the price specified in the Disposition Notice or any
price in excess thereof and otherwise on substantially the same terms set
forth in the Disposition Notice; provided, that if such sale is not
consummated within such 90-day period (or the agreement to sell entered into
in such 90 day period is not thereafter performed in accordance with its
terms), then the provisions of this Section 7 will again apply to the sale of
such Shares.
(e) For purposes of the Agreement, a "Change in Control Event"
shall be deemed to have occurred if (i) any person has a n acquired
beneficial ownership of more than 50% (excluding the Shares) of the
outstanding shares of Common Stock or (ii) the Grantor shall have entered
into an agreement, including without limitation an agreement in principle,
providing for a merger or other business combination involving the Grantor or
the acquisition of 30% or more of the assets of the Grantor and its
subsidiaries, taken as a whole.
8. Repurchase of Shares. If a Change in Control Event has not
occurred prior to the first anniversary date of the Merger Termination Date,
then beginning on such anniversary date, the Grantor shall have the right to
purchase (the "Repurchase Right") all, but not less than all, of the Shares
at the greater of (i) the Purchase Price, or (ii) the average closing price
of the Common Stock on the Nasdaq National Market for the five trading days
ending five days prior to the date the Grantor gives written notice of its
intention to exercise the Repurchase Right. If the Grantor does not exercise
the Repurchase Right within 30 days following the first anniversary of the
Merger Termination Date, the Repurchase Right shall terminate. In the event
the Grantor wishes to exercise the Repurchase Right, the Grantor shall send a
written notice to the Grantee specifying a date (not later than 10 business
days and not earlier than two business days following the date such notice is
given) for the closing of such purchase.
9. Registration Rights.
(a) In the event that the Grantee shall desire to sell any of the
Shares within three years after the purchase of such Shares pursuant hereto,
and such sale requires, in the opinion of counsel to the Grantee, which
option shall be reasonably satisfactory to the Grantor and its counsel,
registration of such Shares under the Securities Act, the Grantor will
cooperate with the Grantee and any underwriters registering such Shares for
resale, including, without limitation, promptly filing a registration
statement which complies with the requirements of applicable federal and
state securities laws and entering into an underwriting agreement with such
underwriters upon such terms and conditions as are customarily contained in
underwriting agreements with respect to secondary distributions; provided
that the Grantor shall not be required to have declared effective more than
two registration statements hereunder and shall be entitled to delay the
filing or effectiveness of any registration statement for up to 120 days if
the offering would, in the judgment of the Board of Directors of the Grantor,
require premature disclosure of any material corporate development or
otherwise interfere with or adversely affect any pending or proposed offering
of securities of the Grantor or any other material transaction involving the
Grantor.
(b) If the Common Stock is registered pursuant to the provisions
of this Section 9, the Grantor agrees (i) to furnish copies of the
registration statement and the prospectus relating to the Shares covered
thereby in such numbers as the Grantee may from time to time reasonably
request and (ii) if any event shall occur as a result of which it becomes
necessary to amend or supplement any registration statement or prospectus, to
prepare and file under the applicable securities laws such amendments and
supplements as may be necessary to keep available for at least 90 days a
prospectus covering the Common Stock meeting the requirements of such
securities laws, and to furnish to the Grantee such numbers of copies of the
registration statement and prospectus as amended or supplemented as may
reasonably be requested. The Grantor shall bear the cost of the
registration, including, but not limited to, all registration and filing
fees, printing expenses, and fees and disbursements of counsel and
accountants for the Grantor, except that the Grantee shall pay the fees and
disbursements of its counsel and the underwriting fees and selling
commissions applicable to the Shares sold by the Grantee. The Grantor shall
indemnify and hold harmless Grantee, its affiliates and its officers and
directors from and against any and all losses, claims, damages, liabilities
and expenses arising out of or based upon any statements contained in,
omissions or alleged omissions from, each registration statement filed
pursuant to this paragraph; provided, however, that this provision does not
apply to any loss, liability, claim, damage or expense to the extent it
arises out of any statement or omission made in reliance upon and in
conformity with written information furnished to the Grantor by the Grantee,
its affiliates or its officers expressly for use in any registration
statement (or any amendment thereto) or any preliminary prospectus filed
pursuant to this paragraph. The Grantor shall also indemnify and hold
harmless each underwriter and each person who controls any underwriter within
the meaning of either the Securities Act or the Securities Exchange Act of
1934 against any and all losses, claims, damages, liabilities and expenses
arising out of or based upon any statements contained in, omissions or
alleged omissions from, each registration statement filed pursuant to this
paragraph; provided, however, that this provision does not apply to any loss,
liability, claim, damage or expense to the extent it arises out of any
statement or omission made in reliance upon and in conformity with written
information furnished to the Grantor by the underwriters expressly for use in
any registration statement (or any amendment thereto) or any preliminary
prospectus filed pursuant to this paragraph.
10. Profit Limitation.
(a) Notwithstanding any other provision of this Agreement, in no
event shall the Grantee's Total Profit (as hereinafter defined) exceed $125
million (the "Profit Limit") and, if it otherwise would exceed such amount,
the Grantee, at its sole election, shall either (i) deliver to the Grantor
for cancellation Shares previously purchased by Grantee, (ii) pay cash or
other consideration to the Grantor, or (iii) undertake any combination
thereof, so that Grantee's Total Profit shall not exceed the Profit Limit
after taking into account the foregoing actions.
(b) Notwithstanding any other provision of this Agreement, the
Option may not be exercised for a number of Shares as would, as of the date
of the Exercise Notice, result in a Notional Total Profit (as defined below)
of more than the Profit Limit and, if exercise of the Option otherwise would
exceed the Profit Limit, the Grantee, at its discretion, may increase the
Purchase Price for that number of Shares set forth in the Exercise Notice so
that the Notional Total Profit shall not exceed the Profit Limit; provided,
that nothing in this sentence shall restrict any exercise of the Option
permitted hereby on any subsequent date at the Purchase Price set forth in
Section 1(a) hereof.
(c) As used herein, the term "Total Profit" shall mean the
aggregate amount (before taxes) of the following: (i) the amount of cash
received by Grantee pursuant to Section 8.03(c) of the Merger Agreement,
(ii) (x) the amount received by Grantee pursuant to the Grantor's repurchase
of Shares pursuant to Sections 1(d), 7 or 8 hereof, less (y) the Grantee's
purchase price for such Shares, (iii) the amount received by Grantee in
respect of a Cash Exercise Notice pursuant to Section 1(d) hereof, and
(iv) (x) the net cash amounts received by Grantee pursuant to the sale of
Shares (or any other securities into which such Shares are converted or
exchanged) to any unaffiliated party, less (y) the Grantee's purchase price
for such Shares.
(d) As used herein, the term "Notional Total Profit" with respect
to any number of Shares as to which Grantee may propose to exercise the
Option shall be the Total Profit determined as of the date of the Exercise
Notice assuming that the Option were exercised on such date for such number
of Shares and assuming that such Shares, together with all other Shares held
by Grantee and its affiliates as of such date, were sold for cash at the
closing market price for the Common Stock as of the close of business on the
preceding trading day (less customary brokerage commissions).
11. Expenses. Each party hereto shall pay its own expenses
incurred in connection with this Agreement, except as otherwise specifically
provided herein.
12. Specific Performance. The Grantor acknowledges that if the
Grantor fails to perform any of its obligations under this Agreement,
immediate and irreparable harm or injury would be caused to the Grantee for
which money damages would not be an adequate remedy. In such event, the
Grantor agrees that the Grantee shall have the right, in addition to any
other rights it may have, to specific performance of this Agreement.
Accordingly, if the Grantee should institute an action or proceeding seeking
specific enforcement of the provisions hereof, the Grantor hereby waives the
claim or defense that the Grantee has an adequate remedy at law and hereby
agrees not to assert in any such action or proceeding the claim or defense
that such a remedy at law exists. The Grantor further agrees to waive any
requirement for the securing or posting of any bond in connection with
obtaining any such equitable relief.
13. Notice. All notices, requests, demands and other
communications hereunder shall be deemed to have been duly given and made if
in writing and if served by personal delivery upon the party for whom it is
intended or delivered by registered or certified mail, return receipt
requested, or if sent by facsimile transmission, upon receipt of oral
confirmation that such transmission has been received, to the person at the
address set forth below, or such other address as may be designated in
writing hereafter, in the same manner, by such person.
If to the Grantor: Viking Office Products, Inc.
000 Xxxx 000xx Xxxxxx
Xxxxxxxx, Xxxxxxxxxx 00000
Attn: Xxxxx Xxxxxx, President
Telecopy: (000) 000-0000
With a copy to: Xxxxxx & Xxxxxxx
000 X Xxxxxx, Xxxxx 0000
Xxx Xxxxx, XX 00000-0000
Attn: Xxxx Xxxxxx Xxxxxx, Esq.
Telecopy: (000)000-0000
If to the Grantee: Office Depot, Inc.
0000 Xxx Xxxxxxxxxx Xxxx
Xxxxxx Xxxxx, Xxxxxxx 00000
Attn: Xxxxx Xxxxxxxxx, Executive Vice President
Telecopy: (000) 000-0000
With a copy to: Xxxxxxx Xxxxxxx & Xxxxxxxx
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
Attn: Xxxx X. Xxxx, Esq.
Telecopy: (000) 000-0000
14. Parties in Interest. Nothing in this Agreement, express or
implied, is intended to confer upon any person other than the Grantor or the
Grantee, or their successors or assigns, any rights or remedies under or by
reason of this Agreement.
15. Entire Agreement; Amendments. This Agreement, together with
the Merger Agreement and the other documents referred to therein, contains
the entire agreement between the parties hereto with respect to the subject
matter hereof and supersedes all prior and contemporaneous agreements and
understandings, oral or written, with respect to such transactions. The
terms of this Agreement may be amended, modified or waived only by an
agreement in writing signed by the party against whom such amendment,
modification or waiver is sought to be enforced.
16. Assignment. No party to this Agreement may assign any of its
rights or obligations under this Agreement without the prior written consent
of the other party hereto, except that the Grantee may assign its rights and
obligations hereunder to any direct or indirect wholly-owned subsidiary of
the Grantee (provided that such assignment shall not relieve the Grantee of
its obligations hereunder if such transferee does not perform such
obligations). Any Shares sold or transferred by the Grantee to any other
person or entity in compliance with the terms hereof (other than a direct or
indirect wholly-owned subsidiary of the Grantee) shall no longer have the
benefit of the rights provided for herein with respect to such Shares
(including without limitation those set forth in Sections 1(d) and 9) and
shall no longer be subject to the restrictions or rights in favor of the
Grantor provided for herein with respect to such Shares (including without
limitation those set forth in Sections 7 and 8).
17. Headings. The section headings herein are for convenience
only and shall not affect the construction of this Agreement.
18. Counterparts. This Agreement may be executed in any number of
counterparts, each of which, when executed, shall be deemed to be an original
and all of which together shall constitute one and the same document.
19. Governing Law. This Agreement shall be governed by and
construed in accordance with the laws of the State of Delaware (regardless of
the laws that might otherwise govern under applicable Delaware principles of
conflicts of law).
20. Survival. All representations and warranties contained in
this Agreement shall survive delivery of and payment for the Shares.
21. Severability. If any term, provision, covenant or restriction
of this Agreement is held by a court of competent jurisdiction to be invalid,
void or unenforceable, the remainder of the terms, provisions, covenants and
restrictions of this Agreement shall remain in full force and effect and
shall in no way be affected, impaired or invalidated.
IN WITNESS WHEREOF, the Grantee and the Grantor have caused this
Agreement to be duly executed and delivered on the day and year first above
written.
OFFICE DEPOT, INC.
By:/s/ Xxxxx X. Xxxxxxxxx
-----------------------
Title: Secretary
VIKING OFFICE PRODUCTS, INC.
By:/s/ Xxxxx Xxxxxxx
-----------------------
Title: Chief Executive Officer
